SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950144-05-003472
Filing Date
2005-04-04
Accepted
2005-04-01 18:54:39
Documents
5
Period of Report
2005-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AAIPHARMA INC. g93884k1e8vk.htm 8-K 22684
2 EX-10.1 g93884k1exv10w1.htm EX-10.1 38858
3 EX-10.2 g93884k1exv10w2.htm EX-10.2 60474
4 EX-99.1 g93884k1exv99w1.htm EX-99.1 6336
5 GRAPHIC g93884k1s9388400.gif GRAPHIC 18953
  Complete submission text file 0000950144-05-003472.txt   149674
Mailing Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405
Business Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405 9102547000
AAIPHARMA INC (Filer) CIK: 0001013243 (see all company filings)

IRS No.: 042687849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21185 | Film No.: 05727156
SIC: 8734 Services-Testing Laboratories